Increased T‐cell stimulating activity by mutated SEC2 correlates with its improved antitumour potency

Aims:  To investigate the improved antitumour activity of SAM‐3 compared with recombinant staphylococcal enterotoxins C2 (rSEC2).

[1]  Xiaogang Wang,et al.  An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity , 2011, Cancer Immunology, Immunotherapy.

[2]  Gabriel Cabrera,et al.  Superantigens Increase the Survival of Mice Bearing T Cell Lymphomas by Inducing Apoptosis of Neoplastic Cells , 2010, PloS one.

[3]  Annette Lee,et al.  Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy , 2010, Journal of Translational Medicine.

[4]  S. Dimauro,et al.  Treatment of CoQ10 Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects , 2010, PloS one.

[5]  K. Omoe,et al.  High Affinity of Interaction between Superantigen and T Cell Receptor Vβ Molecules Induces a High Level and Prolonged Expansion of Superantigen-reactive CD4+ T Cells , 2010, The Journal of Biological Chemistry.

[6]  G. Bohach,et al.  A quantitative real time PCR method to analyze T cell receptor Vβ subgroup expansion by staphylococcal superantigens , 2010, Journal of Translational Medicine.

[7]  Lei Sun,et al.  The pilot study of anti-tumor effects versus immunosuppression of staphylococcal enterotoxin C , 2007, Cancer biology & therapy.

[8]  Todd A Fehniger,et al.  Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. , 2007, Immunity.

[9]  L. Fox,et al.  Long-Term Staphylococcal Enterotoxin C1 Exposure Induces Soluble Factor-Mediated Immunosuppression by Bovine CD4+ and CD8+ T Cells , 2006, Infection and Immunity.

[10]  N. Terrazzini,et al.  The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength. , 2006, International immunology.

[11]  Xu Ming-kai,et al.  Gene expression and function study of fusion immunotoxin anti-Her-2-scFv—SEC2 in Escherichia coli , 2006, Applied Microbiology and Biotechnology.

[12]  E. Wardelmann,et al.  Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer , 2005, International journal of cancer.

[13]  S. Sahn,et al.  Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. , 2004, Chest.

[14]  H. Johnson,et al.  Superantigen enhanced protection against a weak tumor‐specific melanoma antigen: Implications for prophylactic vaccination against cancer , 2001, International journal of cancer.

[15]  C. Chiou,et al.  Development and use of PCR primers for the investigation of C1, C2 and C3 enterotoxin types of Staphylococcus aureus strains isolated from food-borne outbreaks. , 2001, International journal of food microbiology.

[16]  U. Andersson,et al.  The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens , 1999, British Journal of Cancer.

[17]  R. Schwartz,et al.  Anergy and Cytokine-Mediated Suppression as Distinct Superantigen-Induced Tolerance Mechanisms in Vivo , 1999, The Journal of experimental medicine.

[18]  Hongmin Li,et al.  Crystal structure of a T-cell receptor β-chain complexed with a superantigen , 1996, Nature.

[19]  V. Poli,et al.  Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice , 1996, The Journal of experimental medicine.

[20]  B. A. Fields,et al.  Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. , 1996, Nature.

[21]  K. Acharya,et al.  Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. , 1995, Structure.

[22]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[23]  S. Ostrand-Rosenberg.  Tumor immunotherapy: the tumor cell as an antigen-presenting cell. , 1994, Current opinion in immunology.

[24]  P. Doherty.  Cell-mediated cytotoxicity , 1993, Cell.

[25]  P. Marrack,et al.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins , 1993, Infection and immunity.

[26]  C. Smith,et al.  Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2 , 1992, Infection and immunity.

[27]  T. Kalland,et al.  Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity. , 1991, Current topics in microbiology and immunology.

[28]  C. Benoist,et al.  Superantigens interact with MHC class II molecules outside of the antigen groove , 1990, Cell.

[29]  M. Misfeldt.  Microbial "superantigens" , 1990, Infection and immunity.

[30]  P. Marrack,et al.  The staphylococcal enterotoxins and their relatives. , 1990, Science.

[31]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.